The most recent 13F filing that Foster & Motley Inc.
Made with the Securities and Exchange Commission revealed that the company increased the number of Omega Healthcare Investors, Inc. (NYSE: OHI) shares it held during the third quarter.
A total of 131,538 shares of stock in the real estate investment trust were acquired by the fund at the cost of approximately $3,879,000. The percentage of Omega Healthcare Investors owned by Foster & Motley Inc.
As of the end of the most recent reporting period was 0.06%.
Several other hedge funds have also changed their stakes in the company in the most recent period.
During the second quarter, Capital Analysts LLC added 23.1% more Omega Healthcare Investors stock to its holdings, bringing the total percentage of that company’s stock to 100%.
Because of the purchase of an additional 302 shares throughout the month, Capital Analysts LLC now has 1,612 shares of the $45,000 real estate investment trust. This brings the company’s total share count to its current level.
A 1.6% increase in the proportion of Omega Healthcare Investors stock that Avantax Advisory Services Inc. owned as of the third quarter was reflected in that company’s ownership percentage.
After making subsequent purchases totaling 336 shares, Avantax Advisory Services Inc. now owns 21,321 shares of the real estate investment trust, which are estimated to have a value of $629,000.
During the third quarter, Global Trust Asset Management LLC made a 3.8% purchase of additional Omega Healthcare Investors stock, bringing the total percentage of that company’s shares it owned to 100%. Following the acquisition of an additional 350 shares over time, Global Trust Asset Management LLC now has 9,650 shares of the real estate investment trust. These shares have a combined value of $285,000 in the current market. Jacobi Capital Management LLC raised the proportion of Omega Healthcare Investors in which it had an investment by 4.9% during the second quarter. Jacobi Capital Management LLC now owns a total of 7,448 shares of the real estate investment trust, which are currently valued at $210,000 thanks to subsequent purchases that added 351 shares and were made over time.
And finally, during the second quarter, Mckinley Capital Management LLC, based in Delaware, increased the amount of Omega Healthcare Investors stock owned by one percent.
As a result of the purchase of 404 additional shares during the most recent quarter, the Delaware-based McKinley Capital Management LLC now directly owns a total of 39,496 shares in the real estate investment trust, which have a value of $1,113,000.
At the moment, institutions hold the majority share of the equity in the company, which is 63.58%.
The first day of trading for OHI was Monday, and the opening price was $28.24. The stock price is currently trading at a moving average of $29.09 for the past 50 days and a moving average of $30.51 for the past 200 days. Omega Healthcare Investors, Inc. hit a low of $24.81 over the past year, while the company reached a high of $33.71 over the same period. The debt-to-equity ratio is 1.36, the current ratio is 2.77, and the quick ratio is also 2.77. The stock is trading at a price corresponding to a price-to-earnings ratio of 16.21, and its beta value is 0.99. The company’s stock currently has a market value of $6.61 billion.
Due to recent research on the topic, OHI has been the subject of multiple investigations. Omega Healthcare Investors was downgraded from a “neutral” rating to an “underperform” rating by Credit Suisse Group, which also established a price objective of $25.00 for the company. On January 9, the results of a study were made available to the general public. Robert W.
Baird announced a reduction in the price target they had set for Omega Healthcare Investors from $32.00 to $29.00 in a research report made public on Friday, January 13. The report was made public on Friday, January 13. Omega Healthcare Investors was the topic of the first article published in the research section of StockNews.com. That article went live on October 12 and can be found here. They recommended that shareholders “hold” their shares of the company.
Bank of America lowered its target price for Omega Healthcare Investors from $35.00 to $33.00.
It changed its rating for the company from “buy” to “neutral” in a research report published on Monday, November 14. The report was about Omega Healthcare Investors.
In addition, they moved Omega Healthcare Investors from a “buy” rating to a “neutral” rating on their recommendation scale.
In a research report published on Wednesday, November 9, Omega Healthcare Investors was given an “outperform” rating, and Raymond James increased their price objective for the company from $34.00 to $35.00. Raymond James Research Report on Omega Healthcare Investors was the name of the report that discussed the company’s stock and was written by Raymond James. One of the equity research analysts has assigned a sell rating to the stock; seven have suggested that investors keep their current positions; and one has assigned a buy rating to the stock.
According to data from Bloomberg, the current rating for Omega Healthcare Investors is “Hold,” and the price target has been established at $30.89. This information was obtained from the market research firm Thomson Reuters.
Omega’s primary focus is the real estate industry, and the company operates as a real estate investment trust. The assisted livin’
Leave a comment